Nasus Pharma Ltd. (NSRX)
NYSEAMERICAN: NSRX · Real-Time Price · USD
7.00
+0.25 (3.70%)
At close: Nov 19, 2025, 4:00 PM EST
7.00
0.00 (0.00%)
After-hours: Nov 19, 2025, 8:00 PM EST
Nasus Pharma Market Cap
Nasus Pharma has a market cap or net worth of $63.42 million as of November 19, 2025.
Market Cap
63.42M
Enterprise Value
64.94M
1-Year Change
n/a
Ranking
Category
Stock Price
$7.00
Market Cap Chart
Since the IPO on August 14, 2025, Nasus Pharma's market cap has decreased from $72.08M to $63.42M, a decrease of -12.02%. That is a compound annual growth rate of -38.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2025 | 61.15M | -3.98% |
| Nov 17, 2025 | 63.69M | -5.13% |
| Nov 14, 2025 | 67.13M | -6.20% |
| Nov 13, 2025 | 71.57M | 4.08% |
| Nov 12, 2025 | 68.76M | 1.20% |
| Nov 10, 2025 | 67.95M | - |
| Nov 7, 2025 | 67.95M | -0.66% |
| Nov 5, 2025 | 68.40M | -5.63% |
| Nov 4, 2025 | 72.48M | 5.12% |
| Nov 3, 2025 | 68.94M | -2.19% |
| Oct 30, 2025 | 70.48M | 0.39% |
| Oct 29, 2025 | 70.21M | -7.74% |
| Oct 28, 2025 | 76.10M | 5.66% |
| Oct 27, 2025 | 72.02M | 0.76% |
| Oct 24, 2025 | 71.48M | 3.82% |
| Oct 23, 2025 | 68.85M | 1.20% |
| Oct 22, 2025 | 68.04M | 0.09% |
| Oct 21, 2025 | 67.97M | -2.18% |
| Oct 20, 2025 | 69.49M | -2.04% |
| Oct 17, 2025 | 70.94M | -1.14% |
| Oct 16, 2025 | 71.75M | 0.25% |
| Oct 15, 2025 | 71.57M | 3.27% |
| Oct 14, 2025 | 69.31M | -1.29% |
| Oct 13, 2025 | 70.21M | 0.65% |
| Oct 10, 2025 | 69.76M | -0.65% |
| Oct 9, 2025 | 70.21M | 6.60% |
| Oct 8, 2025 | 65.86M | 0.83% |
| Oct 7, 2025 | 65.32M | 2.27% |
| Oct 6, 2025 | 63.87M | 3.52% |
| Oct 3, 2025 | 61.70M | 9.13% |
| Oct 2, 2025 | 56.53M | 4.00% |
| Oct 1, 2025 | 54.36M | -9.77% |
| Sep 30, 2025 | 60.25M | -11.92% |
| Sep 29, 2025 | 68.40M | -5.63% |
| Sep 26, 2025 | 72.48M | -0.62% |
| Sep 25, 2025 | 72.93M | 0.63% |
| Sep 24, 2025 | 72.48M | -0.12% |
| Sep 23, 2025 | 72.57M | 0.13% |
| Sep 22, 2025 | 72.48M | -0.16% |
| Sep 18, 2025 | 72.59M | -1.38% |
| Sep 17, 2025 | 73.61M | -0.06% |
| Sep 16, 2025 | 73.65M | 0.74% |
| Sep 12, 2025 | 73.11M | -0.86% |
| Sep 11, 2025 | 73.75M | 1.88% |
| Sep 10, 2025 | 72.39M | -0.14% |
| Sep 9, 2025 | 72.49M | -0.11% |
| Sep 8, 2025 | 72.57M | 0.38% |
| Sep 5, 2025 | 72.30M | -0.38% |
| Sep 4, 2025 | 72.57M | -0.86% |
| Sep 3, 2025 | 73.20M | 0.50% |
| Sep 2, 2025 | 72.84M | -0.74% |
| Aug 29, 2025 | 73.38M | 0.62% |
| Aug 28, 2025 | 72.93M | -0.12% |
| Aug 27, 2025 | 73.02M | 0.37% |
| Aug 26, 2025 | 72.75M | 0.50% |
| Aug 25, 2025 | 72.39M | -1.96% |
| Aug 22, 2025 | 73.84M | -4.12% |
| Aug 21, 2025 | 77.01M | 2.41% |
| Aug 20, 2025 | 75.19M | -4.49% |
| Aug 19, 2025 | 78.73M | 1.16% |
| Aug 18, 2025 | 77.82M | 6.05% |
| Aug 15, 2025 | 73.38M | 1.81% |
| Aug 14, 2025 | 72.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 922.29B |
| Johnson & Johnson | 481.86B |
| AbbVie | 413.34B |
| UnitedHealth Group | 284.05B |
| AstraZeneca | 276.37B |
| Novartis AG | 244.75B |
| Merck & Co. | 239.34B |
| Abbott Laboratories | 226.05B |